Senta Voss

Title: Senta Voss: Innovator in Pharmaceutical Formulations

Introduction

Senta Voss is a prominent inventor based in Mainz, Germany. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative drug delivery systems. With a total of 2 patents, her work has the potential to impact the treatment of various diseases.

Latest Patents

Senta Voss's latest patents include an aqueous pharmaceutical formulation comprising the anti-PD-L1 antibody Avelumab. This invention relates to a novel formulation that enhances the efficacy of the antibody in therapeutic applications. Another notable patent is for a process for producing nanoparticles laden with active ingredients. This process involves several steps, including the dissolution of active compounds in an organic solvent, mixing with an aqueous phase, evaporation of the solvent, and purification of the resulting nanoparticles through dialysis.

Career Highlights

Throughout her career, Senta Voss has worked with leading companies in the pharmaceutical industry, including Merck Patent GmbH and Pfizer Corporation. Her experience in these organizations has allowed her to refine her expertise in drug formulation and development.

Collaborations

Senta has collaborated with notable colleagues such as Markus Weigandt and Gianluca Rinaldi. These partnerships have contributed to her innovative work and the advancement of pharmaceutical technologies.

Conclusion

Senta Voss is a trailblazer in the field of pharmaceutical innovations, with her patents paving the way for new treatment options. Her contributions to drug formulation and nanoparticle technology highlight her role as a key inventor in the industry.